Examples of using Mycophenolate in English and their translations into Hungarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
Mycophenolate mofetil is the 2-morpholinoethyl ester of MPA.
In experimental models, mycophenolate mofetil was not tumourigenic.
Imuran) and mycophenolate mofetil(CellCept).
Each capsule contains 250 mg mycophenolate.
The active substance is mycophenolate mofetil.
azathioprine, mycophenolate mofetil, corticosteroids and cytotoxic antibodies.
Patients treated with immunosuppressants, including Mycophenolate mofetil Teva, are at increased risk for opportunistic infections(bacterial,
with some patients also taking azathioprine or mycophenolate mofetil.
if you get pregnant while taking Mycophenolate mofetil Teva.
The total body clearance of basiliximab was reduced by an average 51% when mycophenolate mofetil was added to a regimen consisting of ciclosporin for microemulsion and corticosteroids.
The following transplant medications have been administered in clinical trials with Zenapax without any interactions: cyclosporine, mycophenolate mofetil, gancyclovir,
safety of Advagraf and Prograf, both in combination with mycophenolate mofetil(MMF) and corticosteroids, was compared in 667 de novo kidney transplant recipients.
In recent years, mycophenolate mofetil(CellCept) has been used as an effective medication for lupus,
such as ciclosporin, corticosteroids, azathioprine and mycophenolate mofetil.
Reduced levels of ciclosporin, mycophenolate mofetil and tacrolimus have been reported in transplant patients when coadministered with Renagel without any clinical consequences(i. e graft rejection).
Concomitant use of Zenapax with another antilymphocyte antibody therapy in the context of intensive immunosuppression with cyclosporine, mycophenolate mofetil and corticosteroids may be a factor leading to fatal i dic.
Mycophenolate is a powerful human teratogen,
The use of Mycophenolate mofetil Teva is not recommended during pregnancy
Patients receiving immunosuppressive regimens involving combinations of medicinal products, including mycophenolate, are at increased risk of developing lymphomas
Because mycophenolate mofetil has demonstrated teratogenic effects in rats